Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Entera Bio FY 2024 GAAP EPS $(0.25), Sales $181.000K Beat $139.000K Estimate

Author: Benzinga Newsdesk | March 28, 2025 03:09pm
Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.25) per share. The company reported quarterly sales of $181.000 thousand which beat the analyst consensus estimate of $139.000 thousand by 30.22 percent.

Posted In: ENTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist